Combating Antimicrobial Resistance: A Global Imperative

Why in news?

Antimicrobial resistance (AMR) poses an increasingly urgent threat to global public health, rendering once-effective treatments ineffective and challenging our ability to combat infectious diseases.
As global leaders convene to address this pressing issue, the Global Leaders Group (GLG) on Antimicrobial Resistance has released a comprehensive report outlining key strategies and targets for action.

AMR occurs when bacteria, viruses, fungi, and parasites evolve to resist the effects of antimicrobial medicines, such as antibiotics and antivirals.
This phenomenon is driven primarily by the misuse and overuse of these medications in humans, animals, and agriculture.
As a result, infections become harder to treat, leading to increased morbidity, mortality, and healthcare costs.

AMR is already responsible for nearly 5 million deaths annually, with a significant portion occurring in children under the age of five. In 2019 alone, bacterial AMR directly caused 1.27 million deaths globally and contributed to 4.95 million deaths overall.
Without decisive action, AMR is projected to lower life expectancy, increase healthcare costs, and incur substantial economic losses.

The GLG report emphasizes the urgent need for adequate, predictable, and sustainable financing to address AMR, including efforts to bolster research and development for new antibiotics.
It proposes global targets to reduce deaths caused by bacterial AMR, increase the use of responsible antibiotics in humans, and decrease antimicrobial use in agri-food systems.
Additionally, the GLG recommends that all countries develop outcome-oriented targets and timelines to guide their efforts.

Several global initiatives are underway to address AMR, including the adoption of a One Health approach that integrates human health, animal health, and environmental sectors.
The Global Action Plan on Antimicrobial Resistance, adopted in 2015, aims to tackle AMR through coordinated action across multiple sectors.
The Quadripartite Joint Secretariat on Antimicrobial Resistance facilitates collaboration between key organizations, including the World Health Organization (WHO), the Food and Agriculture Organization (FAO), the United Nations Environment Programme (UNEP), and the World Organisation for Animal Health (WOAH).
High-level meetings and awareness campaigns, such as World AMR Awareness Week, further amplify efforts to combat AMR on a global scale.

Addressing AMR requires a coordinated, multi-sectoral approach at the national and international levels.
Adequate funding, strengthened surveillance and monitoring systems, and increased investments in research and development are essential components of an effective response.
By implementing targeted interventions, setting clear targets, and fostering global collaboration, we can mitigate the impact of AMR and safeguard the effectiveness of antimicrobial medicines for generations to come.

As global leaders convene to address antimicrobial resistance, the release of the GLG report underscores the urgent need for collective action to combat this growing threat.
By prioritizing responsible antimicrobial use, investing in research and development, and adopting a One Health approach, we can work towards a future where AMR no longer poses a significant risk to global health and well-being.